Alnylam Assist™: Support for Every Step
Hi, I’m Natalie
I'm here to support you throughout your treatment experience and have been specifically assigned to help you with questions you may have about Alnylam Assist™ and ONPATTRO® (patisiran).
Monday - Friday, 8am - 6pm ET
How We Can Help
Now that you or your loved one have been prescribed ONPATTRO, Alnylam Assist™ is here to help support you.
Each person is unique—your support should be that way, too. Alnylam Assist™ is designed to be truly personalized: a support team who is easily accessible and adaptable. So if your support needs change during treatment, your level of support can change, too.
Get the Support You Need
After you begin treatment with ONPATTRO and enroll in Alnylam Assist™, your dedicated Case Manager and the Alnylam Assist™ team will provide ongoing support in 3 key areas:
Understanding Your Benefits
Review and verify your insurance benefit coverage for ONPATTRO treatment.
Financial Assistance Options
Alnylam Assist™ provides financial assistance options for qualifying individuals. Your Case Manager will work with you to determine eligibility.*
* Patients must meet specified eligibility criteria to qualify for assistance. Alnylam reserves the right to make eligibility determinations and to modify or discontinue any program at any time.
Disease and Treatment Education
Materials to help educate you and your family on hATTR amyloidosis and treatment.
Support for Your Journey
In addition to personalized support from your Case Manager, Alnylam Assist™ can help educate you and your loved ones about hATTR amyloidosis and connect you with advocacy organizations that are involved in the hATTR amyloidosis community.
Our Message to Caregivers
We're here to support you while you support your loved ones
We understand that support is more than insurance, and that you can be affected by hATTR amyloidosis, too. Alnylam Assist™ is here to help you navigate the day-to-day treatment experience, while you navigate everything else. Don't worry, you're in the right place.